ADVANCED PLANT PHARMACEUTICALS ANNOUNCES RECEIPT OF INITIAL ORDER FOR ITS AIDS DRUG FROM BRAZILIAN PHARMACEUTICAL DISTRIBUTOR.WEST ORANGE, NJ--(BUSINESS WIRE)--Dec. 13, 1994--Advanced Plant Pharmaceuticals, Inc. (OTC Bulletin Board OTC Bulletin Board An electronic quotation listing of the bid and asked prices of OTC stocks that do not meet the requirements to be listed on the NASDAQ stock-listing system. : APPID APPID Application Identifier ) ("APPI APPI American Psychiatric Publishing, Inc. APPI American Psychiatric Publishing Inc. APPI American Psychiatric Press, Inc. APPI Atmospheric Pressure Photoionization APPI Advanced Peer-to-Peer Internetworking APPI Advanced Plant Pharmaceuticals Inc. ") today announced that it received an initial order, totalling $260,000, for its drug Perthon from MG Pharmaco Brasil LTDA LTDA Limitada (Portuguese; similar to Limited Liability Company) LTDA Limitada (Spanish) LTDA London Taxi Drivers Association LTDA Lower Tier Defended Area LTDA Low Temperature Die Attach , a Brazilian pharmaceutical distributor. APPI recently signed an exclusive Brazilian distribution rights agreement with MG Pharmaco Brasil LTDA. Perthon is an oral, phyto-pharmaceutical (plant-based) drug that has demonstrated an ability to raise suppressed immune system levels and to increase hemoglobin and accelerate weight gain in AIDS patients. Based on the results of clinical testing completed in Australia, and subsequent OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). approval of Perthon from Australia's Therapeutic Goods Administration The Therapeutic Goods Administration or TGA is the regulatory body for therapeutic goods (including medicines, medical devices, gene technology, and blood products) in Australia. , as well as additional clinical data compiled in Australia, the Brazilian health authorities have granted MG Pharmaco Brasil LTDA initial approval to begin selling the drug to Brazilian hospitals and doctors for use in treating the estimated 500,000 HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. positive individuals living in Brazil. C.J. Lieberman, President and Chief Executive Officer of APPI, commented, "We expect that this exclusive Brazilian distribution rights agreement with MG Pharmaco Brasil LTDA represents the first step in APPI's worldwide marketing program for Perthon. Distribution rights for other South American and Central American countries are currently being negotiated, and we anticipate overseas market sales of Perthon, commencing with Brazil, should increase substantially beginning in mid- 1995. APPI's proprietary technology standardizes plant substances for regulatory approval as a drug while consistently maintaining the plants' vital properties and efficacies. We intend to further capitalize on this technology by pursuing joint venture agreements with drug companies worldwide, assisting these companies in attaining FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approval for their plant based drugs." Advanced Plant Pharmaceuticals, Inc. is a phyto-pharmaceutical (plant derived products) company, whose mission is to research, develop, produce, and distribute botanically based therapeutics. APPI received the first IND from the Food and Drug Administration for a herbal product.
CONTACT: Advanced Plant Pharmaceuticals Equity Group Inc.
C.J. Lieberman, President & CEO Devin Sullivan
(914) 362-4129 (212) 836-9608
Robert Goldstein
(212) 371-8660
|
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion